Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Facet Blood Lancets

K-Number: K222539 · 2022-11-18

Decision Date2022-11-18
Product CodeQRL
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Facet Blood Lancets is a medical device manufactured by Facet Technologies, LLC. It received FDA 510(k) clearance on 2022-11-18 under approval number K222539. The device is classified under product code QRL. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Facet Blood Lancets?

Facet Blood Lancets is a medical device that received FDA 510(k) clearance on 2022-11-18. It is manufactured by Facet Technologies, LLC. The 510(k) number is K222539.

When was Facet Blood Lancets approved by the FDA?

Facet Blood Lancets received FDA 510(k) clearance on 2022-11-18, under approval number K222539.

What company makes Facet Blood Lancets?

Facet Blood Lancets is manufactured by Facet Technologies, LLC.

What is the FDA product code for Facet Blood Lancets?

The FDA product code for Facet Blood Lancets is QRL.

Other Devices by Facet Technologies, LLC

Related Devices (Code: QRL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.